Results 21 to 30 of about 29,880 (268)

Prescription drug monitoring programs operational characteristics and fatal heroin poisoning [PDF]

International Journal of Drug Policy, 2019
Silvia S Martins, Nathan Smith, Ariadne Rivera-Aguirre   +2 more
exaly   +2 more sources

Helpful, Unnecessary, or Harmful: A Systematic Review of the Effects of Prescription Drug Monitoring Program Use on Opioid Prescriptions

Pharmacoepidemiology, 2023
Prescription drug misuse is a global problem, especially in the United States (US). Clinician involvement is necessary in this crisis, and prescription drug monitoring programs (PDMPs) are a recommended tool for the prevention, recognition, and ...
Nina Z. Y. Smith, J. Douglas Thornton, Susan H. Fenton, Debora Simmons, Tiffany Champagne-Langabeer   +4 more
doaj   +1 more source

Barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools in Australia

Frontiers in Public Health, 2023
IntroductionReal time prescription monitoring tools have been implemented in Australia to address the growing concerns of drug misuse, drug-related mortality and morbidity. The objective of this pilot study is to investigate the barriers and facilitators
Dimi Hoppe, Chaojie Liu, Hanan Khalil
doaj   +1 more source

Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs [PDF]

Pain Medicine, 2018
Marcus A Bachhuber, Brendan Saloner
exaly   +2 more sources

Mitigating Prescription Opioid Risk: Prescription Drug Monitoring Programs

, 2019
Background: Opioid-related morbidity and mortality is a serious public health issue in the United States. Prescription Drug Monitoring Program (PDMP) review prior to prescribing opioids has consistently been recommended as best practices for risk mitigation, however, access/utilization of this monitoring program remains low.
Vigue, Brenda
openaire   +3 more sources

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians [PDF]

Health Affairs, 2016
Yuhua Bao, Feijun Luo, Bruce R Schackman   +2 more
exaly   +2 more sources

Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions [PDF]

Health Affairs, 2018
Yuhua Bao, Katherine Wen, Philip J Jeng   +2 more
exaly   +2 more sources

Prescribed stimulant medications: Trends in the last decade, pre and post COVID-19 response

Exploratory Research in Clinical and Social Pharmacy, 2023
Background: Recent studies indicate that COVID-19 has had a significant impact on access and continuity to opioid and benzodiazepine medications; little is known about its effect on access to and utilization of stimulant medications.
Meelee L. Kim, Netrali Dalvi, Danielle DeNufrio Valerio, Gail K. Strickler, Leonard D. Young   +4 more
doaj   +1 more source

Consumo de antibióticos en atención primaria en población adulta de Asturias durante el periodo 2014-2020

Atención Primaria, 2022
Resumen: Objetivo: Estudiar la evolución del consumo de antibióticos en población adulta en el ámbito de Atención Primaria (AP) del Servicio de Salud del Principado de Asturias (SESPA) durante 2014-2020.
María Luisa Nicieza García, Pablo Pérez Solís, Constanza Gómez de Oña, Patricio Suárez Gil, Valeria Rolle Sóñora, Belén Suárez Mier   +5 more
doaj   +1 more source

Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse [PDF]

Journal of Policy Analysis and Management, 2018
AbstractDespite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non‐medical ...
Anca M, Grecu, Dhaval M, Dave, Henry, Saffer   +2 more
openaire   +2 more sources